Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors - Concepedia

Concepedia

Publication | Open Access

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

DOI Full Paper Access

23

Citations

27

References

2024

Year

Nikhil I. Khushalani, Patrick A. Ott, Robert L. Ferris, Tina Cascone, Dirk Schadendorf, Dung T. Le, Manish Sharma, Fabrice Barlési, William H. Sharfman, Jason J. Luke,

Journal for ImmunoTherapy of Cancer

Abstract

NCT02110082; NCT02253992.

References

	Year	Citations

Page 1